No vaccine-related serious adverse events (SAEs) or sustained Grade 3 or higher adverse events related to the vaccine reportedSOUTH SAN ...

Adults who received the updated mRNA-1273 COVID-19 vaccine experienced a lower risk for hospitalization compared with NVX-CoV2705 recipients.

The study also reviews the great potential of mRNA vaccines to treat influenza, RSV, cancer, and autoimmune diseases.

A comprehensive new review published in The Lancet affirms that currently approved mRNA vaccines are safe and highly ...

Online content falsely claiming vaccines can be distributed through the food supply has circulated for years and a new series ...

Among healthy adults receiving the JN.1- or KP.2-adapted mRNA seasonal COVID-19 vaccine, neutralizing antibody responses were similar.

A massive, global review of mRNA vaccines has shown that they are very effective and safe. Reporting in The Lancet, ...

A sweeping global review led by researchers at the University of British Columbia has found that mRNA vaccines—now ...

MRNA vaccines are effective and safer than getting COVID-19, according to a large-scale review published in The Lancet, which ...

"After billions of doses, we now have an extraordinary amount of scientific evidence." The post Huge Survey Finds the Truth ...

VRBPAC endorsed mRNA-1010 for adults 50-64 and ≥65 years, unanimously concluding benefits outweighed risks, supporting a late-stage regulatory path toward potential first mRNA seasonal influenza ...

A review of billions of mRNA vaccine doses finds strong COVID protection across groups, with rare serious side effects ...